We all understand that the main goal of pharmacy practice is to provide patients with appropriate and necessary pharmaceutical products and services. Pharmacy is a patient-oriented profession.
Pharmacy regulatory compliance is an essential component of successful pharmacy practice. There have been several recent reports of problematic pharmacy practices that I feel the need to share so that we can all learn from them and develop regulatory compliance systems to avoid them. Each one points to a system any community pharmacy can check today: technician training, compounding documentation, patient identification at pickup, and readiness for a board inspection.
What Is Pharmacy Regulatory Compliance?
Pharmacy regulatory compliance is the set of systems a pharmacy uses to meet the laws, regulations, and professional standards that govern its work. Those include state board of pharmacy rules, federal FDA and DEA requirements, USP compounding standards, and the pharmacy’s own written policies and procedures. Compliance lives in daily practice: training, supervision, documentation, and verification.
Case 1: Improperly Compounded Pediatric Clonidine Suspension in Kentucky
In March 2026, the Kentucky Board of Pharmacy concluded that a pharmacy did not meet the standard of practice for non-sterile compounding of pediatric clonidine suspension, resulting in the hospitalization of three pediatric patients. The pharmacy was fined $5,000 and is barred from compounding for five years. The pharmacist owner and pharmacist-in-charge (PIC) has surrendered his pharmacy license. The major findings of the Board were:
- Inadequate pharmacy technician training.
- Failure to monitor each compounding employee.
- A systematic and multifaceted lack of adequate documentation.
The takeaway message of this case is that although the major focus of pharmacy regulation is on sterile compounding, it is also very important to follow standard procedures for non-sterile compounding. The consequences of regulatory noncompliance can be significant for patients, for pharmacies, and for pharmacists.
What this means for your pharmacy: non-sterile compounding isn’t limited to dedicated compounding pharmacies. If anyone on your team prepares an oral suspension, the same three findings apply: documented technician training, pharmacist oversight of every compounding employee, and complete compounding records.
Read the Kentucky Board of Pharmacy’s announcement of the final resolution.
Case 2: How Can Pharmacies Prevent Wrong-Patient Dispensing Errors?
The Healthcare Providers Service Organization (HPSO) has published a description of a wrong-patient dispensing error in which a patient was given medication that was intended for a different patient. The patient was hospitalized and the patient’s attorney sent a demand letter for compensation based on the medical expenses and injuries. The defense contended that a reasonable and prudent patient should notice the incorrect patient name, incorrect drug name, and incorrect directions on the pharmacy label. The conclusion was that this blame-shifting argument would not carry the day at trial. The claim was settled out of court.
The report indicates that it had been the pharmacy policy to read the patient’s name and date of birth to the person picking up the prescription for recipient confirmation. The report suggests that the better approach is for a pharmacy team member to ask the person picking up the prescription to recite the patient’s name and date of birth, for pharmacy confirmation.
What this means for your pharmacy: pickup is the last checkpoint before a wrong-patient error reaches the patient. Changing who states the name and date of birth costs nothing and closes the gap HPSO identified. How the team treats the patient after an error matters too, and it can decide whether a complaint becomes a lawsuit.
Case 3: Unsafe Practice and Refusal to Transfer Prescriptions in New Jersey
The New Jersey Board of Pharmacy has issued an order requiring a pharmacist to sell her pharmacy. The pharmacist’s license has been suspended. These regulatory actions followed allegations that the pharmacist had dispensed the wrong strengths of medications, and had dispensed medications in containers with broken safety seals and missing dosage units. The pharmacist continued to practice after the Board had issued the license suspension order. When patients requested that their prescriptions be transferred to other pharmacies, the pharmacist allegedly refused to perform the transfer.
What this means for your pharmacy: wrong strengths, broken seals, and missing dosage units are the kinds of findings that surface during a board of pharmacy inspection. And a board order is not a suggestion. Continuing to practice under a suspension turned a disciplinary matter into a forced sale.
Read the New Jersey Attorney General’s announcement.
Three Pharmacy Compliance Cases at a Glance
Case | What went wrong | Consequence | Lesson for your pharmacy |
|---|---|---|---|
Kentucky compounding | Untrained technician, no monitoring, poor documentation | $5,000 fine, 5-year compounding bar, PIC license surrendered | Document training and oversight for anyone who compounds |
HPSO wrong patient | Patient identity confirmed by reading it aloud | Hospitalization, demand letter, settlement | Have the person at pickup state name and date of birth |
New Jersey practice | Wrong strengths, broken seals, missing units, refused transfers | License suspended, ordered to sell pharmacy | Check stock integrity routinely; comply with board orders |
Why Every Practice Site Needs a Regulatory Compliance Expert
I think we can all agree that safe and effective pharmacy practice requires clinical expertise in the application of evidence-based knowledge and skills. The three cases reviewed above suggest that it is equally important to have expertise in regulatory compliance and risk management. Every pharmacy practice site needs at least one team member who can legitimately claim that expertise. It is not just a matter of common sense. There are principles and practices that can be learned and implemented.
I invite you to register for PharmCon freeCE’s 8-hour MasteryRx course: Regulatory and Risk Management Essentials for Community Pharmacy Leadership. The course picks up where these three cases leave off, with modules on compounding regulations, order processing errors, inspection preparedness, and handling a patient after an error. It also covers declining prescriptions, the duty to counsel, alert fatigue, and immunization liability, all taught through real legal cases.
In each of these cases, the warning signs were there before anyone was harmed or disciplined: a technician without documented training, a pickup routine that let the wrong patient say yes, stock that no one was checking. The best time to find a gap like that is before a board inspector or a patient’s attorney does.
You can become the “go to” person for expertise in pharmacy law at your practice site. Register for Regulatory and Risk Management Essentials for Community Pharmacy Leadership and start with the modules that matter most to your pharmacy.
Managing a pharmacy team? Ask about group pricing and the Organization Portal for tracking team CE.
FREQUENTLY ASKED QUESTIONS
In the three cases above: inadequate technician training, lack of supervision, poor documentation, weak patient identification, compromised drug integrity, and continuing to practice under a board order.
Yes. USP standards for non-sterile compounding apply wherever non-sterile preparations are compounded, including retail and independent pharmacies. State boards decide how those standards are adopted and enforced, so requirements vary by state.
Ask the patient, or the person picking up, to state the patient’s name and date of birth, rather than reading the information aloud and waiting for confirmation.
The course offers 8 hours of CE across eight modules. Credit is earned per module, so you do not have to complete the whole series to receive credit. Access lasts one year from purchase.
Community pharmacists and pharmacy leaders, including pharmacists-in-charge and managers responsible for compliance at their practice site.
David B. Brushwood, BSPharm, JD, FAPhA, Professor Emeritus at the University of Florida College of Pharmacy and Senior Lecturer at the University of Wyoming School of Pharmacy.
